United States · FDA National Drug Code directory
Triamterene and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 33342-467_96024781-b8d8-452f-ab9c-6c9ab07b34ea
- Product NDC
- 33342-467
- Form
- CAPSULE
- Composition / generic term
- Triamterene and Hydrochlorothiazide
- Labeler
- Macleods Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250128
- Source listing expiry
- 20261231
Source-listed ingredients
- TRIAMTERENE — 37.5 mg/1
- HYDROCHLOROTHIAZIDE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (33342-467-11) · 33342-467-11
- 1000 CAPSULE in 1 BOTTLE (33342-467-44) · 33342-467-44
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →